anymedi, Inc.
KKRX:390110246.00
KRW
-43.00
(-14.88%)
ISIN
KR7390110005
Return %
Stock
S&P 500
1Y
-81.99
14.39
3Y
-92.53
81.42
5Y
- -
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Hanam-si South Korea
- IPO Date
- Dec 21, 2022
- Website
- anymedi.com
- Similar Companies
- Business
- anymedi, Inc. is a South Korea-based medical technology company engaged in the development, manufacturing, and commercialization of patient-specific surgical guides, customized medical implants, and artificial intelligence-driven surgical planning solutions. Founded in 2016 and headquartered in Seoul, South Korea, the company operates within the healthcare equipment and supplies sector, utilizing advanced medical imaging analysis, three-dimensional (3D) computer-aided design, and precision 3D printing technologies to deliver customized clinical solutions. The company operates primarily through three business segments: Patient-Specific Surgical Guides, Customized Aesthetic Solutions, and Medical Simulation and Software Services. Its product and service portfolio includes patient-customized surgical guides for breast-conserving surgery (BCS) in breast cancer treatment; congenital heart disease surgical simulation models; customized surgical guides and anatomical models for orthopedic and thoracic procedures, including spinal fusion, pelvic fracture reconstruction, and maxillofacial surgery; innofit, a customized facial aesthetic solution providing patient-tailored rhinoplasty silicone implants designed via virtual 3D CT simulation; innofit Lab digital design and consultation services for plastic surgery clinics; cloud-based medical image processing and surgical planning software platforms; and high-precision anatomical models used for preoperative simulation, clinical training, and patient education. anymedi, Inc. serves university hospitals, general medical centers, and specialized plastic surgery clinics across South Korea, while expanding its distribution and clinical partnerships in international markets across the Asia-Pacific region and North America. In recent developments, anymedi, Inc. has expanded its commercial portfolio and technological capabilities through strategic initiatives and product advancements. The company has deepened clinical deployment of its surgical guide platform through collaborative research and clinical agreements with major domestic tertiary medical institutions to support health insurance reimbursement pathways and clinical validation. In the aesthetic healthcare division, the company has expanded the affiliated network for its innofit brand, upgraded its proprietary 3D facial simulation software, and enhanced its digital consultation infrastructure. Furthermore, anymedi, Inc. has accelerated the integration of artificial intelligence into its cloud-based surgical design software to automate image segmentation, reduce customized device turnaround times, and support overseas regulatory registrations.